logo
logo

Varda Space Industries announces $187 million in Series C funding, led by Natural Capital and Shrug Capital, to enhance microgravity medicine manufacturing.

Jul 10, 2025•about 1 month ago

Amount Raised

$187 Million

Round Type

series c

El SegundoBiotechnologyManufacturing

Investors

Also CapitalLux CapitalCaffeinated CapitalKhosla VenturesPeter ThielFounders FundShrug CapitalNatural Capital

Description

Varda Space Industries announced a Series C fundraising round, totaling $329 million raised to date. The $187 million round was led by Natural Capital and Shrug Capital, with participation from notable investors. The funding will support Varda's pharmaceutical lab development for microgravity drug formulations. The company operates unique orbital laboratories for innovative drug production in space.

Company Information

Company

Varda Space Industries

Location

El Segundo, California, United States

About

Varda Space Industries is making reentry as common as launch. We are building the infrastructure for a thriving orbital economy and enabling foundational science, from in-orbit pharmaceutical processing to reliable and economical hypersonic reentry capsules.

Related People

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech